Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Explorative Study on the Association of High Sensitivity C-Reactive Protein (hsCRP) and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma

NCT04303975 is registered in ClinicalTrials.gov with Jiarong Chen, MD as lead sponsor.

NCT NCT04303975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04303975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Explorative Study on the Association of High Sensitivity C-Reactive Protein (hsCRP) and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma
Lead sponsor
Jiarong Chen, MD
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2021
Completion date
December 31, 2021
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, nasopharyngeal carcinoma, toxicity due to radiotherapy